title: RON Signaling Is a Key Mediator of Tumor Progression in Many Human Cancers.
abstract: With an increasing body of literature covering RON receptor tyrosine kinase function in different types of human cancers, it is becoming clear that RON has prominent roles in both cancer cells and in the tumor-associated microenvironment. RON not only activates several oncogenic signaling pathways in cancer cells, leading to more aggressive behavior, but also promotes an immunosuppressive, alternatively activated phenotype in macrophages and limits the antitumor immune response. These two unique functions of this oncogene, the strong correlation between RON expression and poor outcomes in cancer, and the high tolerability of a new RON inhibitor make it an exciting therapeutic target, the blocking of which offers an advantage toward improving the survival of cancer patients. Here, we discuss recent findings on the role of RON signaling in cancer progression and its potential in cancer therapy.
authors.affiliation: Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah 84112.
authors.forename: Najme
authors.initials: N
authors.lastname: Faham
authors.affiliation: Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah 84112.
authors.forename: Alana L
authors.initials: AL
authors.lastname: Welm
mesh_terms: D000818:Animals; D018450:Disease Progression; D006801:Humans; D007165:Immunosuppression Therapy; D009369:Neoplasms / Q000378:metabolism* / Q000628:therapy*; D020794:Receptor Protein-Tyrosine Kinases / Q000378:metabolism*; D015398:Signal Transduction / Q000502:physiology; D059016:Tumor Microenvironment / Q000502:physiology*
chemical_list: C080835:RON protein; D020794:Receptor Protein-Tyrosine Kinases